Bangkok Genomics Innovation PCL (BKK:BKGI) Total Inventories: ฿36.1 Mil (As of Dec. 2025)


BKK:BKGI Bangkok Genomics Innovation PCL BKK:BKGI
45 GF Score
Price ฿2.04
! 12 Warning Signs
View Full Analysis

What is Bangkok Genomics Innovation PCL Total Inventories?

Bangkok Genomics Innovation PCL BKK:BKGI +0.99% 45 Total Inventories is ฿36.1 Mil as of Dec. 2025. GuruFocus rates BKK:BKGI with a GF Score™ of 45/100. The stock has 12 warning signs investors should review.

Bangkok Genomics Innovation PCL's total inventories for the quarter that ended in Dec. 2025 was ฿36.1 Mil. Bangkok Genomics Innovation PCL's average total inventories from the quarter that ended in Sep. 2025 to the quarter that ended in Dec. 2025 was ฿31.7 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Bangkok Genomics Innovation PCL's Net-Net Working Capital per share for the quarter that ended in Dec. 2025 was ฿0.32.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Bangkok Genomics Innovation PCL's Days Inventory for the three months ended in Dec. 2025 was 34.96.

Inventory Turnover measures how fast the company turns over its inventory within a year. Bangkok Genomics Innovation PCL's Inventory Turnover for the quarter that ended in Dec. 2025 was 2.61.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Bangkok Genomics Innovation PCL's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 0.22.

Bangkok Genomics Innovation PCL  (BKK:BKGI) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Bangkok Genomics Innovation PCL's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2025 is

Net-Net Working Capital Per Share (Q: Dec. 2025 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(221.744+0.75 * 138.511+0.5 * 36.085-148.704
-0-1.925)/600.000
=0.32

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Bangkok Genomics Innovation PCL's Days Inventory for the three months ended in Dec. 2025 is calculated as:

Days Inventory=Average Total Inventories (Q: Dec. 2025 )/Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=31.7385/82.831*365 / 4
=34.96

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Bangkok Genomics Innovation PCL's Inventory Turnover for the quarter that ended in Dec. 2025 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Dec. 2025 ) / Average Total Inventories (Q: Dec. 2025 )
=82.831 / 31.7385
=2.61

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Bangkok Genomics Innovation PCL's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=31.7385 / 142.264
=0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Bangkok Genomics Innovation PCL Total Inventories Related Terms

Bangkok Genomics Innovation PCL Total Inventories Historical Data

* Premium members only.

The historical data trend for Bangkok Genomics Innovation PCL's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bangkok Genomics Innovation PCL Total Inventories Chart

Bangkok Genomics Innovation PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Inventories
Get a 7-Day Free Trial 16.75 20.27 10.05 22.09 36.09

Bangkok Genomics Innovation PCL Quarterly Data
Dec19 Dec20 Dec21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.09 20.50 21.77 27.39 36.09
BKK:BKGI
45GF Score
Bangkok Genomics Innovation PCL BKK:BKGI
Total Inventories is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bangkok Genomics Innovation PCL Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Frequently Asked Questions Learn more about Total Inventories →
What does a Total Inventories of ฿36.1 Mil mean?
Bangkok Genomics Innovation PCL (BKK:BKGI) has a Total Inventories of ฿36.1 Mil as of Dec. 2025. The total amount of inventory as recorded on a company's balance sheet. View historical data for Bangkok Genomics Innovation PCL and its competitors.
Is Bangkok Genomics Innovation PCL's Total Inventories too high?
Bangkok Genomics Innovation PCL's current Total Inventories is ฿36.1 Mil. Overall, Bangkok Genomics Innovation PCL has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does Bangkok Genomics Innovation PCL's Total Inventories compare to TMO and DHR?
Bangkok Genomics Innovation PCL's Total Inventories of ฿36.1 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Medical Diagnostics & Research company?
A good Total Inventories depends on the Medical Diagnostics & Research industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Bangkok Genomics Innovation PCL and its competitors. Bangkok Genomics Innovation PCL's current Total Inventories is ฿36.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bangkok Genomics Innovation PCL stock overvalued right now?
Bangkok Genomics Innovation PCL (BKK:BKGI) has a current Total Inventories of ฿36.1 Mil. The current Total Inventories is ฿36.1 Mil. Bangkok Genomics Innovation PCL's overall GF Score™ is 45/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Bangkok Genomics Innovation PCL (BKK:BKGI), the current Total Inventories is ฿36.1 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bangkok Genomics Innovation PCL Business Description

Address 3689 Rama 4 Road, Phra Khanong Subdistrict, Khlong Toei Subdistrict, Bangkok, THA, 10110
Bangkok Genomics Innovation PCL operate a laboratory and provide medical analysis services. Its services includes Screening for genetic abnormalities in reproductive health (Reproductive Health Testing Services),Infectious Disease Analysis Product Group (Infectious - Related Testing Services), Other screening product groups (Other Testing Services), providing technology services (Tech Solution Services), and Sales of other medical products Related (Medical - Related Products). Its segments include Sale of laboratory reagents and related products; Testing and analysis services, which derives maximum revenue; and Sale and advanced therapy medicinal product.
45GF Score

Get the complete analysis for BKK:BKGI

Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿2.04
Price